Cargando…

Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia

BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world. Although the treatment landscape for CLL is rapidly evolving, there are still some patients who develop drug resistance or disease refractory. Ferroptosis is a type of lipid peroxidation–induced cell dea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Bihui, Li, Yue, Xu, Zhangdi, Miao, Yi, Yin, Hua, Kong, Yilin, Zhang, Xinyu, Liang, Jinhua, Xia, Yi, Wang, Li, Li, Jianyong, Wu, Jiazhu, Xu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582233/ https://www.ncbi.nlm.nih.gov/pubmed/36275721 http://dx.doi.org/10.3389/fimmu.2022.962000

Ejemplares similares

Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia
por: Xu, Zhangdi, et al.
Publicado: (2023)

Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia
por: Gao, Rui, et al.
Publicado: (2023)

NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases
por: Zou, Yixin, et al.
Publicado: (2018)

98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia
por: Shi, Ke, et al.
Publicado: (2019)

A simplified prognostic score for T-cell large granular lymphocyte leukaemia
por: Liu, Hailing, et al.
Publicado: (2023)

PB1946: NOTCH PATHWAY MUTATION CONTRIBUTES TO INFERIOR PROGNOSIS IN HBV-INFECTED CHRONIC LYMPHOCYTIC LEUKEMIA
por: Shang, Chunyu, et al.
Publicado: (2023)

Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis
por: Wu, Wei, et al.
Publicado: (2019)

Phenotypic alteration of CD8(+) T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming
por: Wu, Jiazhu, et al.
Publicado: (2016)

The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia
por: Sha, Yeqin, et al.
Publicado: (2022)

PB1931: LOW SERUM CHOLESTEROL LEVEL AS A SIGNIFICANT PROGNOSTIC FACTOR IMPROVES CLL-IPI IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Gao, Rui, et al.
Publicado: (2023)

Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia
por: Li, Heng, et al.
Publicado: (2017)

Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
por: Zhang, Jing, et al.
Publicado: (2022)

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid
por: Wu, Wei, et al.
Publicado: (2016)

A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia
por: Gong, Han, et al.
Publicado: (2022)

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
por: Zou, Yixin, et al.
Publicado: (2018)

MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene
por: Qin, Shu-Chao, et al.
Publicado: (2017)

Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies
por: Gu, Danling, et al.
Publicado: (2021)

t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review
por: Chen, Weifeng, et al.
Publicado: (2016)

Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis
por: Gao, Rui, et al.
Publicado: (2020)

Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia
por: Wang, Jinghua, et al.
Publicado: (2022)

Low prevalence and independent prognostic role of del(11q) in Chinese patients with chronic lymphocytic leukemia
por: Zou, Yi-Xin, et al.
Publicado: (2021)

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
por: Tang, Jing, et al.
Publicado: (2023)

Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study
por: Wu, Jiazhu, et al.
Publicado: (2021)

Overexpression of c-Myc-dependent heterogeneous nuclear ribonucleoprotein A1 promotes proliferation and inhibits apoptosis in NOTCH1-mutated chronic lymphocytic leukemia cells
por: Zou, Yixin, et al.
Publicado: (2022)

Ferroptosis in acute leukemia
por: Lyu, Tianxin, et al.
Publicado: (2023)

Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort
por: Miao, Yi, et al.
Publicado: (2023)

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
por: Yun, Xiaoya, et al.
Publicado: (2020)

Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis
por: Peng, Li-Peng, et al.
Publicado: (2022)

Super-Enhancer–Associated nine-gene prognostic score model for prediction of survival in chronic lymphocytic leukemia patients
por: Liang, Xue, et al.
Publicado: (2022)

Prognosis Factors in Chronic Lymphocytic Leukemia
por: Ivanescu, AM, et al.
Publicado: (2012)

Prognostic Roles of Glucose to Lymphocyte Ratio and Modified Glasgow Prognosis Score in Patients With Non-small Cell Lung Cancer
por: Yang, Ming, et al.
Publicado: (2022)

Exploring the significance of PAK1 through chromosome conformation signatures in ibrutinib‐resistant chronic lymphocytic leukaemia
por: Wu, Zijuan, et al.
Publicado: (2022)

SF3B1 mutation is a prognostic factor in chronic lymphocytic leukemia: a meta-analysis
por: Zhang, Zhenghao, et al.
Publicado: (2017)

HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia
por: Zhang, Xiaoning, et al.
Publicado: (2022)

P1214: CTPS1 ACTS AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA
por: Ren, Yi-Min, et al.
Publicado: (2023)

The Role of Ferroptosis-Related Molecules and Significance of Ferroptosis Score in Cervical Cancer
por: Li, Pengxiang, et al.
Publicado: (2022)

Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
por: Xia, Yi, et al.
Publicado: (2023)

P773: CYCLOPHOSPHAMIDE COMBINED WITH PREDNISONE FOR CYCLOSPORINE-REFRACTORY/RELAPSED T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA ASSOCIATED PURE RED CELL APLASIA
por: Liu, Xiaoqing, et al.
Publicado: (2023)

Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score
por: Shou, Yanhong, et al.
Publicado: (2020)

Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia
por: Miao, Yi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_71qlpq7k2njop6dk1m7n26ngpd